[Heterogeneity of Response to PD-1/PD-L1 Inhibitors in Elderly Patients with Advanced NSCLC under the Background of Immunosenescence and Intervention Strategies].
- DOI
- 10.3779/j.issn.1009-3419.2026.101.05
- Published
- 2026 Mar 20
- Container
- Zhongguo fei ai za zhi = Chinese journal of lung cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3779/j.issn.1009-3419.2026.101.05,
title = {[Heterogeneity of Response to PD-1/PD-L1 Inhibitors in Elderly Patients with Advanced NSCLC under the Background of Immunosenescence and Intervention Strategies].},
author = {Huang Y and Wang Y and Wei A and Xiong Y and Duan M and Xu T and He W},
year = {2026},
journal = {Zhongguo fei ai za zhi = Chinese journal of lung cancer},
doi = {10.3779/j.issn.1009-3419.2026.101.05},
url = {https://doi.org/10.3779/j.issn.1009-3419.2026.101.05}
}RIS
TY - JOUR TI - [Heterogeneity of Response to PD-1/PD-L1 Inhibitors in Elderly Patients with Advanced NSCLC under the Background of Immunosenescence and Intervention Strategies]. AU - Huang Y AU - Wang Y AU - Wei A AU - Xiong Y AU - Duan M AU - Xu T AU - He W PY - 2026 JO - Zhongguo fei ai za zhi = Chinese journal of lung cancer DO - 10.3779/j.issn.1009-3419.2026.101.05 UR - https://doi.org/10.3779/j.issn.1009-3419.2026.101.05 ER -
APA
Y, H., Y, W., A, W., Y, X., M, D., T, X., & W, H. (2026). [Heterogeneity of Response to PD-1/PD-L1 Inhibitors in Elderly Patients with Advanced NSCLC under the Background of Immunosenescence and Intervention Strategies].. Zhongguo fei ai za zhi = Chinese journal of lung cancer. https://doi.org/10.3779/j.issn.1009-3419.2026.101.05
Source records
- pubmed · retrieved 2026-09-27T12:27:27.465Z